Balloon ablation catheters market seen reaching $2.04B by 2030

By AI, Created 5:20 PM UTC, May 18, 2026, /AGP/ – The balloon ablation catheters market is projected to grow from $1.28 billion in 2025 to $1.4 billion in 2026, with The Business Research Company forecasting $2.04 billion by 2030. Demand is rising as atrial fibrillation cases increase and cardiac care shifts toward minimally invasive and imaging-linked procedures.

Why it matters: - Balloon ablation catheters are used to treat abnormal heart rhythms with minimally invasive procedures. - The market’s growth points to rising demand for catheter-based cardiac care, especially for atrial fibrillation and other arrhythmias. - The projected expansion also signals continued investment in advanced energy delivery and imaging integration for heart procedures.

What happened: - The Business Research Company released a 2026 market report on balloon ablation catheters. - The report estimates the market will rise from $1.28 billion in 2025 to $1.4 billion in 2026. - The report projects the market will reach $2.04 billion by 2030. - The company published the report on May 14, 2026, from London. - The report covers market conditions across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also made a free sample request page and the full market report available online.

The details: - Balloon ablation catheters use an inflatable balloon at the catheter tip and energy delivery systems such as radiofrequency, cryo, laser or thermal elements. - The balloon inflates to occlude targeted areas and create circumferential lesions that disrupt abnormal electrical pathways in heart tissue. - The report links near-term growth to rising cardiac arrhythmias, wider use of minimally invasive ablation procedures, catheter technology advances, greater awareness of cardiovascular disease and more cardiac care facilities in hospitals. - The forecast period is driven by higher demand for atrial fibrillation treatments, broader use of advanced energy delivery methods, more catheter-based therapies in specialty clinics, growth in ambulatory surgical centers and tighter integration with imaging and monitoring technologies. - The report says the main trends include more single-use balloon ablation catheters, rising use of radiofrequency and cryo balloon catheters, broader applications for reusable catheters and stronger real-time imaging integration. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow fastest during the forecast period as healthcare infrastructure improves and access to advanced cardiac treatments expands. - The Centers for Disease Control and Prevention said in March 2024 that an estimated 12.1 million people in the U.S. are projected to have atrial fibrillation by 2050.

Between the lines: - The report suggests the market is moving from broad adoption of catheter ablation toward more specialized, technology-linked procedures. - The emphasis on single-use devices and real-time imaging points to hospital demand for speed, precision and lower procedural complexity. - Asia-Pacific’s faster growth forecast reflects a gap between established markets and regions still building access to advanced cardiac care.

What’s next: - The market is projected to keep expanding through 2030 as atrial fibrillation treatment demand rises. - Specialty clinics and ambulatory surgical centers are likely to take on a larger role in catheter-based cardiac care. - Further gains may come from better integration of catheter systems with imaging and monitoring tools.

The bottom line: - Balloon ablation catheters are moving from a niche cardiac device category into a faster-growing segment tied to aging populations, arrhythmia treatment and minimally invasive care.